Medium-dose prednisolone pulse therapy in alopecia areata

Area of Science:

• Dermatology
• Immunology

Background:

• Alopecia areata etiology remains unclear.
• Systemic prednisolone is effective but has side effects.
• Need for safer, effective alopecia areata treatments.

Purpose of the Study:

• Evaluate efficacy and safety of short-term, medium-dose pulse prednisolone.
• Assess treatment response in various alopecia areata forms.

Main Methods:

• Prospective, monocenter study.
• 23 patients with active alopecia areata.
• Intravenous 100 mg prednisolone pulse therapy over 3 days, repeated monthly for three courses.

Main Results:

• 84% of multifocal alopecia areata patients showed marked improvement.
• One ophiasis type patient responded after third course, with relapse.
• Alopecia areata totalis and universalis patients did not respond.
• No major side effects observed.

Conclusions:

• Three monthly courses of medium-dose prednisolone pulse therapy are effective and well-tolerated for active, multifocal alopecia areata.
• Treatment is less effective for alopecia areata totalis/universalis.
• Pulse prednisolone offers a viable option for specific alopecia areata subtypes.